When first reported in 1995, the mammalian Ste20-like kinases (Mst) 1 and 2 were so named both for their similarity to the yeast kinase Ste20 and for the fact that their function was, to us, a deep mystery. While much remains to be explained about the regulation and role of these kinases, the veil has been at least partly raised on the Msts, revealing unexpected modes of activation and function. Work in model organisms suggests a central growthsuppressive role for Mst orthologs, with intriguing possible links to other established tumor suppressors. This minireview underlines our current understanding of how Mst1 and Mst2 are regulated, and how activation of these proteins influences cell survival and proliferation.
The mammalian Ste20-like kinases Mst1 and Mst2 are closely related, evolutionarily conserved serine/threonine protein kinases that play an important role in cell proliferation, survival, morphology, and motility. In Drosophila, the Mst1/2 ortholog Hippo clearly has tumor suppressor activity, and it is suspected, but not proven, that the mammalian Msts may share this property. As such, the Msts have recently become the subjects of intense scrutiny, yet we know relatively little about how these kinases are regulated or the identity of their key substrates.
Mst: A Short History
Mst1 (also known as Stk4 and Krs2) and Mst2 (also known as Stk3 and Krs1) were initially cloned from a lymphoid cDNA library by PCR during a search for human relatives of Saccharomyces cerevisiae Ste20 [1] [2] [3] . Subsequently, these proteins were rediscovered by protein purification as kinases that respond to extreme cellular stress [4] . Mst1 and 2 are closely related to one another and broadly expressed, but are structurally and functionally distinct from Mst3 and Mst4, two other more distantly related kinases with similar names, and from Ysk1/Sok1. Early biochemical experiments revealed that the carboxyl terminus of Mst1 contains a coiled-coil dimerization motif, subsequently termed the SARAH (Salvador, RASSF1, Hippo) domain, which mediates self-association as well as association with other SARAH-domain-containing proteins [5] .
Physiological stimuli for the Msts, and the signaling pathways affected by these kinases, remained obscure until it was realized that a w36 kDa protein kinase observed in apoptotic cells was in fact an amino-terminal, caspasemediated cleavage product of Mst1 [6] . This finding provided an important clue into both the regulation and the cellular function of Mst1, linking it for the first time to a physiological signaling process, namely apoptosis. Soon thereafter, caspase-cleaved Mst1 was shown to shuttle from the cytosol to the nucleus where it was found to play a key role in chromatin condensation during apoptosis [7] . However, it was as a result of discoveries made in Drosophila that a core signaling activity of these kinases was first elucidated. Here, genetic screens for flies with defects in organ size identified Hippo, the Mst1/2 ortholog, as a key regulator of cell growth and survival [8, 9] . Subsequent epistasis experiments placed Hippo atop a tumor suppressor signaling pathway involving the adaptor proteins Salvador (WW45, in man) and MATS (Mob1), the protein kinase WARTS (Lats), and the transcriptional coactivator Yorkie (Yap), which regulates the expression of a number of cell proliferation and survival genes. This model, well-described in a number of recent reviews [10] [11] [12] , forms the basis for our current understanding of Hippo function in flies and may well apply to Mst function in man as well.
Mst Activation: Mysteries Still Abound
What activates the Msts? In flies, it has been suggested that the ezrin-radixin-moesin proteins Merlin (a known tumor suppressor in man) and Expanded lie upstream of Hippo. Additional evidence that Merlin and Mst signaling are related can be inferred from a recent report that shows increased Yap expression and nuclear localization in Merlin-deficient human meningioma cells, as well as rescue of cell-cycle defects in such cells by siRNA-mediated silencing of Yap expression [13] [14] [15] . What is missing, however, is any direct evidence that Merlin associates with or affects the activity of Mst. For these reasons it remains unclear whether Merlin and Mst operate in series or in parallel signaling modules that converge on a final common pathway. Clarifying the relationship between Merlin and Mst is an important goal, as Merlin remains one of the least understood of the classical tumor suppressors and any success in tying the pathways together could have important therapeutic implications.
What we do know about Mst activation can be summarized in three words: cleavage, binding, and phosphorylation ( Figure 1 ). These three processes, alone or in combination, play an important role in regulating Mst activity in a variety of settings. At present, cleavage by caspase-3 remains the best known and only mechanistically understood stimulus for Mst. In this case, cleavage of the regulatory carboxyl terminus liberates a fragment comprising the amino-terminal kinase domain, which is nearly ten times more active than the parent enzyme [16] . This cleavage also separates the aminoterminal kinase domain from nuclear exclusion sequences located in the carboxyl terminus, thus allowing the translocation of the kinase domain from the cytosol to the nucleus and, presumably, offering it a different menu of substrates to phosphorylate.
Proteolytic cleavage is not the sole mechanism of Mst activation, however. Full-length Mst is activated by staurosporine (which is curious, as this is a general and potent kinase inhibitor in most circumstances) as well as by other apoptotic or stress stimuli, including UV radiation, tumor necrosis factor a (TNFa), retinoic acid, serum starvation, heat shock at 55 C, hydrogen peroxide, reactive oxygen species [16] , and various anti-cancer drugs [16] [17] [18] . When activated by such stimuli, Mst autophosphorylates at multiple sites, including key threonine residues in the activation loop, which are likely to play a critical role in activating the enzyme [19, 20] . Mst is also negatively regulated by phosphorylation. For example, Mst1 phosphorylation after epidermal growth factor (EGF) stimulation results in decreased kinase activity, while dephosphorylation in vitro by protein phosphatase 2A (PP2A) restores kinase activity [1] . In addition to activating and inhibiting Mst, phosphorylation can also regulate the sensitivity to cleavage as well as the substrate specificity of Mst. In HEK293 cells, Jang et al. [21] have shown that Akt-mediated phosphorylation of Mst1 on Thr387 renders it resistant to cleavage by caspases, less able to promote apoptosis, and less active towards the pro-apoptotic transcription factor FOXO3, yet more active towards histone H2B. These results are puzzling, as intact Mst1 is mostly cytosolic, and therefore the cleavage-resistant phosphorylated or phosphomimetic form would not be expected to have access to nuclear H2B [22] . These results could be interpreted to mean that the effects of Mst1 on FOXO3 outweigh its effects on H2B, at least in terms of programmed cell death.
Finally, it is clear that Mst activity and/or function is regulated by association with other proteins. In addition to forming SARAH-domain-mediated homodimers, the Mst proteins also heterodimerize with other SARAH-domain-containing proteins. For example, Mst1 and Mst2 heterodimerize with WW45 and with Nore1A/Nore1B, members of the RASSF family of linker proteins that bind activated Ras and Rap GTPases [23] . It appears that Mst-WW45 and Mst-Nore1 complexes are mutually exclusive, as no evidence for a ternary Mst-WW45-Nore1 complex has been found (although the same may not hold true for the related protein Rassf1A, which is reported to co-precipitate with both endogenous Mst2 and WW45 from HeLa cells) [23] . WW45 promotes Mst kinase activity and is itself a target of this kinase [23] . The association of Nore1 with Mst, which is thought to be constitutive, is required for Rap-mediated 'inside-out' integrin signaling in T cells. Here, activation of the small GTPase Rap1 results in the recruitment of Nore1B (also known as RapL), presumably as part of a MstNore1B complex. Mst1 is activated in these circumstances, but not in T cells that lack Nore1B or in cells expressing mutant forms of Nore1B that cannot bind Mst1 [24] . Mst1 activation plays a key role in T-cell development, as Mst1-null mice show decreased numbers of naïve T cells, most likely due to the elimination of prematurely activated T cells [24] . This function is consonant with the general theme of Msts as negative regulators of cell growth and survival. Mature T cells from Mst1-null mice also showed defects in adhesion and motility [25] . Mst1 can in addition bind to other members of the RASSF family, including the aforementioned protein Rassf1A, which liberates Mst from a complex with Raf (in which Mst is inactive) [26] and brings Mst in proximity to active Ras at the plasma membrane, where Mst becomes active [27] . In this case, the meaning of the association between Mst and the adaptor Rassf1A is less clear, as overexpression of Rassf1A has been reported to have both stimulatory and inhibitory effects on Mst activity [28] . Such apparently discordant behavior is not unusual for adaptor proteins: too much Rassf1A might sequester Mst and prevent its activation, whereas lower amounts might assist in activation. Whatever the exact nature of this interaction may be, both the MstNore1B and the Mst-Rassf1A associations link Msts with upstream small GTPases, a theme common to several members of the Ste20 superfamily of protein kinases, such as the p21-activated kinases [29] .
Mst Substrates
Despite the flurry of interest in the Msts that followed the discovery of the Hippo tumor suppressor pathway in flies, we know very little about the cellular substrates of Mst. In fact, the total sum of known substrates is still a single digit number (Figure 2) . Nevertheless, even this small list reveals several interesting facets of Mst function, especially with regard to the role of Mst in promoting apoptosis and inhibiting cell-cycle progression. For example, one of the best-characterized mammalian substrates of Mst1 is H2B, which is phosphorylated at serine 14 in vitro and in apoptotic cells [30] . The phosphorylation is catalyzed by the amino-terminal proteolytic fragment of Mst1 that translocates into the nucleus. Upon phosphorylation by Mst1, the Ser14-phosphorylated form of H2B contributes to chromatin condensation and DNA fragmentation, and thus to the overall cell death program. However, the importance of Mst-catalyzed, H2B Ser14 phosphorylation to chromatin condensation has been challenged by reports that Mst1 also activates JNK, and that activation of Mst1 does not cause chromatin condensation or apoptosis in embryonic stem cells lacking the JNK activators Mkk4 and Mkk7 [31] . These findings suggest that it is caspase-mediated cleavage of Mst1, followed by Mst1-mediated activation of the JNK pathway, rather than direct H2B phosphorylation, that is the mechanism most likely to be responsible for Mst-mediated induction of chromatin condensation during apoptosis. Alternatively, these results may arise from cell-type specific differences.
The FOXO transcription factors represent a second class of Mst substrates that is relevant to its pro-apoptotic effects. When phosphorylated within the forkhead domain by Mst1, FOXO3 can no longer bind 14-3-3. In the absence of 14-3-3 binding, FOXO3 is free to translocate to the nucleus, where it activates a number of pro-apoptotic genes [32] . Interestingly, the anti-apoptotic kinase Akt1 has been shown to phosphorylate Mst1, preventing caspase cleavage of Mst1 and markedly decreasing Mst-mediated FOXO3 phosphorylation [21] . The relationship between Mst1 and Akt appears to be mutually antagonistic, as might be expected for a pro-and an anti-apoptotic kinase, respectively: Akt binds to, phosphorylates, and inhibits Mst1, and Mst1 (and Mst2) inhibits Akt, though it appears that this inhibition is due to the association of these proteins rather than by phosphorylation of Akt by Mst. Recent experiments carried out in neuronal cultures suggest that another member of FOXO family, specifically FOXO1, is a substrate for Mst1 and that this phosphorylation event facilitates FOXO1 translocation into the nucleus by hindering the binding of 14-3-3 to FOXO1. In such cells, Mst1-FOXO1 signaling appears to be important in mediating neuronal death upon deprivation of serum and of neuronal activity [33] .
The AGC-family kinases Ndr1/2 and Lats1/2 are additional substrates of Mst that contribute to apoptosis as well as cellcycle arrest. Both Fas-stimulated and okadaic-acid stimulated phosphorylation and activation of Ndr1/2 are mediated by Mst, which is present in a complex with Ndr and its coactivator, Mob1 [34] [35] [36] . Similarly, Lats-Mob complexes, key elements in the conserved Mst/Hippo pathway, are phosphorylated and activated by Mst [37] . WW45 is required for Mst binding to Lats and facilitates the phosphorylation of Lats by Mst. Lats, in turn, phosphorylates and sequesters Yap in the cytoplasm. Importantly, the related kinases Ndr1 and Ndr2 are unable to bind Yap or to phosphorylate Yap in vitro. In mammals, cytoplasmic retention of the Yorkie ortholog Yap leads to p73 stabilization and induction of expression of the p53-inducible protein Puma, thus promoting apoptosis and cell-cycle arrest [26] . It should be noted that Mst achieves the same ends in Drosophila, but by different means. In Drosophila, Hippo signaling through Warts also leads to the phosphorylation of Yorkie and the induction of apoptosis, but the genes regulated by Yorkie are almost certainly different from those regulated by Yap in mammalian cells. That is, active (unphosphorylated) Yorkie upregulates the expression of the apoptosis inhibitor dIAP, the cell-cycle protein cyclin E, and the microRNA bantam [38, 39] . With the possible exception of cyclin E [13] , the equivalents of these transcriptional targets are not known to be affected by Yap in mammalian cells. Lats can also regulate mitotic exit [40] by binding and inhibiting the actin regulator LIM kinase [41] , resulting in defective actin polymerization and inhibition of cytokinesis.
DAP4 is a constitutively nuclear protein that homodimerizes through its amino terminus and binds Mst1 through its carboxy-terminal region. DAP4 is not significantly phosphorylated by Mst1 and it does not modulate Mst1 kinase activity in vivo or in vitro. However, whereas overexpression of DAP4 does not cause apoptosis, coexpression of DAP4 with Mst1 enhances Mst1-induced apoptosis through a p53-dependent pathway. Mst1 is unable to directly phosphorylate p53. DAP4 binds p53 and possibly brings Mst1 in contact with p53, promoting apoptosis [42] . Interestingly, DAP4 was initially identified as a possible mediator of interferon g (IFNg)-induced apoptosis [43] , but Mst proteins fail to be activated in response to IFNg treatment.
Recently, Sun and colleagues [44] showed that cardiac troponin is a substrate for Mst1. Phosphorylation by Mst1 resulted in conformational changes of cardiac troponin and altered its interactions with other components of the troponin complex. In the heart, activation of Mst causes cardiomyocyte death and dilated cardiomyopathy, suggesting an important role for Mst1 in regulation of cardiac muscle contractility, probably by modulating signaling pathways that control the myofilament function.
Concluding Remarks
Though we have learned a lot about the Msts, much about these kinases remains obscure and, given the potential role of Msts as tumor suppressors, these mysteries are too important to leave unsolved. The major challenges are to uncover the molecular links between cell-surface receptors and Mst activation, to get a more complete picture of Mst substrates, and to determine the functions of the two Mst isoforms in mammalian organisms. Do Merlin and/or the human Expanded homolog activate Mst, and, if so, how? Is this pathway related to or independent of small GTPase/RASSF1 inputs? Regarding the issue of Mst substrates, we need not wait for the next genetic screen in flies; several new bioinformatic and biochemical tools are available that might speed up the hunt in mammalian cells. For example, phosphoproteomic methods have revealed the optimal (and highly unusual) phosphorylation consensus site preferred by Mst1/2 -WYNTMKRR [45] -and this information, encoded in matrix form, could be used to search databases of known phosphopeptides to predict new Mst substrates. In addition, new unbiased schemes to detect direct substrates for protein kinases [46, 47] could and should be brought to bear on this problem. At the level of biochemistry, we know little about the interplay, if any, between Mst1 and Mst2. Do the two Msts form heterodimers, and, if so, is the regulation, location, function, and/or substrate specificity of such heterodimers different from Mst homodimers? In addition, much remains to be learned about Mst genetic functions in mammals. Are Mst1 and Mst2 redundant in mammals, or do they serve unique functions? Are either of these kinases tumor suppressors? Hypermethylation of the Mst1 and Mst2 promoters have been shown to inhibit the WW45-Rassf1-Mst pathway in human sarcomas [48] and loss of cytoplasmic Mst1 has been reported to be a marker for tumor progression in colorectal cancer, suggesting that Mst1 can function as a tumor suppressor [49] . However, the Mst1 knockout mouse is reported to have a surprisingly mild phenotype and does not appear, on its own, to have tumor suppressor function [25, 50] . Whether Mst2, which can replace Hippo function in flies, will have such activity is not known. These and related questions will keep us busy for some time, but it is to be hoped that solving the mystery of the Msts will have a bearing on our evolving understanding of how cells regulate their proliferation and survival.
